These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3917380)

  • 1. Fluorescence polarization immunoassay and enzyme immunoassay compared for free valproic acid in serum ultrafiltrates from epileptic patients.
    Haidukewych D
    Clin Chem; 1985 Jan; 31(1):156. PubMed ID: 3917380
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of fluorescence polarization immunoassay and enzyme immunoassay for free carbamazepine in serum or plasma ultrafiltrates from epileptic patients.
    Haidukewych
    Clin Chem; 1984 Aug; 30(8):1425-6. PubMed ID: 6744614
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and bound valproic acid separated by two methods of ultrafiltration.
    Cramer JA; Bennett DM; Mattson RH
    Clin Chem; 1983 Jul; 29(7):1441-2. PubMed ID: 6407785
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of blood concentration of valproic acid--a comparative study of methods.
    Noda H; Eto S; Minemoto M
    J UOEH; 1985 Mar; 7(1):89-94. PubMed ID: 3920742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy.
    Galimberti CA; Mazzucchelli I; Arbasino C; Canevini MP; Fattore C; Perucca E
    Epilepsia; 2006 Sep; 47(9):1569-72. PubMed ID: 16981874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of theophylline, phenobarbital and valproic acid by chromatographic and immunologic technics. Comparison of methods].
    Vinçon G; Demotes-Mainard F; Bistue C; Jarry C; Brachet-Liermain A; Albin H
    Ann Biol Clin (Paris); 1984; 42(6):427-32. PubMed ID: 6442547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding of valproic acid in maternal and umbilical cord serum.
    Froescher W; Gugler R; Niesen M; Hoffmann F
    Epilepsia; 1984 Apr; 25(2):244-9. PubMed ID: 6423379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
    Fudio S; Carcas A; Piñana E; Ortega R
    J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum levels of free valproic acid].
    de la Morena García E; Borges Domingo MT
    Rev Clin Esp; 1984 Mar; 172(5):257-60. PubMed ID: 6427859
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme immunoassay and gas-liquid chromatography compared for determination of valproic acid in serum.
    Kumps AH; Kumps-Grandjean B; Mardens Y
    Clin Chem; 1981 Oct; 27(10):1788-9. PubMed ID: 6793270
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of free valproic acid: evaluation of the Centrifree system and comparison between high-performance liquid chromatography and enzyme immunoassay.
    Liu H; Montoya JL; Forman LJ; Eggers CM; Barham CF; Delgado M
    Ther Drug Monit; 1992 Dec; 14(6):513-21. PubMed ID: 1485375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total and free valproic acid: plasma level/dose ratio in monotherapy.
    Abadín JA; Durán JA; Sánchez A; Serrano JS
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):221-5. PubMed ID: 2051846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct single-reagent fluorescence polarisation immunoassay for valproic acid in serum.
    Sidki AM; Staley K; Boyes H; Landon J; Williams AH
    J Clin Chem Clin Biochem; 1988 Feb; 26(2):69-74. PubMed ID: 3130457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falsely elevated enzyme-multiplied immunoassay serum valproic acid results in 12 patients.
    Meatherall R; Krahn J
    Ther Drug Monit; 1993 Jun; 15(3):255-7. PubMed ID: 8333007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state kinetics of valproic acid in epileptic patients.
    Bruni J; Wilder BJ; Willmore LJ; Perchalski RJ; Villarreal HJ
    Clin Pharmacol Ther; 1978 Sep; 24(3):324-32. PubMed ID: 357068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid estimation by enzyme immunoassay.
    Elyas AA; Goldberg VD; Ratnaraj N; Lascelles PT
    Ann Clin Biochem; 1980 Nov; 17(6):307-10. PubMed ID: 6782934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme immunochromatographic assay of phenytoin in capillary and venous blood compared with fluorescence polarization immunoassay of plasma from epileptic patients.
    Haidukewych D; Splane ML; Vasos B
    Clin Chem; 1986 Jan; 32(1 Pt 1):204. PubMed ID: 3510092
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.
    Heo G; Kim SH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):758-764. PubMed ID: 28626875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.